Clinical Trial Update: Intravenous Tenecteplase Plus EVT Versus EVT Alone on 4.5 to 24 Hours After Basilar Artery Occlusion [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing intravenous tenecteplase in addition to endovascular therapy versus endovascular therapy alone for basilar artery occlusion; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basilar Artery Occlusion
• Stroke
• Stroke Due to Basilar Artery Occlusion

Drugs mentioned

• Tenecteplase (tenecteplase)

Snippet

Sponsor: The First Affiliated Hospital of University of Science and Technology of China | Conditions: Basilar Artery Occlusion, Acute Cerebrovascular Accident | Phase 3 | Status: COMPLETED